Ilya Yuffa, head of international for US weight-loss drugmaker Eli Lilly, wants Australia to shrink the approval time for new medicines. Dominic Lorrimer Ilya Yuffa, who heads Eli Lilly’s ...

UK cost-effectiveness agency NICE has said that Eli Lilly ... In the same period, Lilly reported sales of $253 million for Emgality, and Teva made $98 million from Ajovy. Novartis is hoping ...

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the plate with a major plan to grow its U.S. footprint. Novartis will ...